CAS 21187-98-4

Gliclazide

Sulfonylurea antidiabetic API for immediate and modified-release tablets

Overview

Gliclazide is part of SAC’s Pharma Excipients & Nutraceuticals range, in Active Pharmaceutical Ingredients. It is supplied as a Powder.

Sulfonylurea antidiabetic API for immediate and modified-release tablets

Pharma Excipients & Nutraceuticals · Active Pharmaceutical Ingredients

Technical information

CAS number21187-98-4
EC number244-260-5
Molecular formula C 15 H 21 N 3 O 3 S
Molecular weight323.4 g/mol
HS heading2935
Physical formPowder

Applications and documentation

Used in

  • Pharmaceuticals (APIs, excipients)

Industries

Synonyms

  • Gliclazide BP
  • Glimicron
  • Diamicron
  • S-852
  • S-1702
  • 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
  • 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
  • J3.151H
  • SE-1702
  • Gliclazidum
  • SE 1702
  • Gliklazid

SDS and TDS are available on request.

Common questions

What applications is this product used for?

Sulfonylurea antidiabetic API for immediate and modified-release tablets

Which grades or packaging options can SAC source?

Grade and packaging are confirmed on quotation for your application. Share your process and targets and we will advise what can be sourced.

Can I request an SDS or TDS?

Yes. SDS and TDS are available on request — use Request a Quote or Contact SAC with the product name.

How do I request a sample or quotation?

Use the buttons on this page. Your product name and CAS number are carried into the contact form automatically.